Neuropsychology of Financial Capacity

Study Overview
=================
Brief Summary
-----------------
The present project aims to investigate the financial capacity in patients diagnosed with Parkinson's Disease or parkinsonism, brain tumor (glioma or meningioma) and cerebrovascular lesion (stroke), in order to evaluate the presence and degree of impairment, and the role of some factors as potential predictors of financial incapacity. The term 'financial capacity' means both operations relating, for example, to asset management or investing money, and activities of daily life such as shopping or using small sums of money; these activities are mediated by different cognitive functions, from numerical and arithmetic skills to decision making. Financial capacity is, in fact, an instrumental activity of daily life (i.e. Instrumental Activity Of Daily Living, I-ADL) whose impairment negatively affects the functional autonomy of the individual, so as to be subject to legal protection. To assess financial capacity, the Numerical Activities of Daily Living - Financial (NADL-F; Arcara et al., 2017) will be administered, a battery of tests aimed at investigating both financial performance and financial competence according to the most recent neuropsychological models proposed in the literature.

Official Title
-----------------
Neuropsychology of Financial Capacity

Conditions
-----------------
Parkinson Disease, Brain Tumor, Stroke

Intervention / Treatment
-----------------
* Behavioral: Neuropsychological tests


Participation Criteria
=================
Eligibility Criteria
-----------------
Inclusion Criteria: age > 18 years Clinical diagnosis of interest for clinical groups For stroke patients: disease duration > 1 month Exclusion Criteria: Other brain disorders different from those of interest Sensory-motor deficits that could prevent neuropsychological assessment Language disorders that could prevent neuropsychological assessment Global cognitive impairment as indexed by MoCA < 26 or MMP < 22.85

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 99 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
Accepts Healthy Volunteers

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Participant Group/Arm | Intervention/Treatment |
| --- | --- |
| Patients with Parkinson's Disease/Parkinsonisms<br> | Behavioral: Neuropsychological tests<br>* Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients<br>|
| Patients with brain tumors<br> | Behavioral: Neuropsychological tests<br>* Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients<br>|
| Patients with ischemic or haemorrhagic stroke<br> | Behavioral: Neuropsychological tests<br>* Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients<br>|
| Healthy Controls<br> | Behavioral: Neuropsychological tests<br>* Neuropsychological assessment with: NADL-F Frontal Assessment Battery (FAB) functional scales assessing activities of daily living (ADL) and instrumental activities of daily living (I-ADL) Mini-Mental Parkinson (MMP) - For Parkinson's Disease patients Montreal Cognitive Assessment (MoCA) - for brain tumor and stroke patients<br>|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Numerical Activity of Daily Living Financial (NADL-F) in Patients with Parkinson's Disease/Parkinsonisms | Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities | At baseline | 
| Numerical Activity of Daily Living Financial (NADL-F) in Patients with ischemic or haemorrhagic stroke | Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities | At baseline | 
| Change from baseline in Numerical Activity of Daily Living - Financial (NADL-F)Patients with brain tumors | Assessment of financial capacity; score range=0-62; higher scores indicate higher financial capacities | At 3 and 12 months follow up | 
| Montreal Cognitive Assessment (MoCA) | Assessment of global cognitive functioning | At baseline | 
| Frontal Assessment Battery (FAB) | Assessment of global cognitive functioning | At baseline | 
| Activities of daily living questionnaire (ADL) | Assessment of function independence in everyday life | At baseline |